StockWatch
·

AJANTA PHARMA LTD. Q4 FY25 Results

AJANTPHARMQ4 FY25 Results
Filing
MetricValue (₹ Cr)vs Q3 FY25
Revenue1.2K2.1%
Total Income1.2K1.0%
Expenditure919.115.7%
PBT269.4112.4%
Net Profit225.263.3%
OPM25.39%5.05pp
NPM18.95%0.84pp
EPS18.003.2%
View full financials

Informational and educational content only. Not investment advice.